From Sleeping Pills to Sleep Science: What a Sleep Medicine Doctor Wants You to Know
Loading player...
Dr. Benji Ozynski (Sleep Health Centre South Africa | Sleep Medicine Doctor) and Nicci Robertson (Executive & Corporate Wellness Coach)
A sleep medicine doctor cuts through the myths, gadget hype, and pill dependency that keep health-conscious adults -- especially perimenopausal and postmenopausal women -- from sleeping well. If you have ever poured a nightcap to wind down, obsessed over your Oura Ring data, or wondered whether your sleeping pill is actually helping, this episode gives you the clinical grounding to stop doing the things that are making it worse.
Dr. Benji Ozynski from the Sleep Health Centre South Africa joins nutritionist Nicci Robertson to explain what sleep actually is, why it cannot be hacked or forced, and what a medically trained sleep specialist looks for before reaching for a prescription pad. They cover how estrogen, progesterone, and vasomotor symptoms derail sleep in perimenopause; why postmenopausal women carry the same obstructive sleep apnea risk as men; and the cardiovascular, metabolic, and neurocognitive consequences of untreated OSA -- from atrial fibrillation and insulin resistance to increased dementia risk.
On sleeping pills, Dr. Ozynski breaks down every major category: benzodiazepines, z-drugs (zolpidem, zopiclone, Stilnox, Ambien), antihistamines, low-dose antipsychotics (quetiapine), older antidepressants (trazodone), and the newer DORA drugs (daridorexant, Quviviq) that block wakefulness rather than force sedation. He explains why tolerance stacking happens, when short-term use is clinically appropriate, and why cognitive behavioural therapy for insomnia (CBT-I) must sit underneath any pharmacological approach.
The episode also addresses why alcohol and THC obliterate REM sleep, what orthosomnia is and why financial penalties tied to wearable sleep scores are likely to backfire, how chronotype is genetically driven and why fighting it is counterproductive, and the three-stage model of how acute stress tips a predisposed brain into chronic insomnia. Practical takeaways include sleep regularity, the one-hour wind-down routine outside the bedroom, caffeine cutoff timing based on adenosine receptor biology, meal timing and blood sugar stability, morning sunlight as a circadian zeitgeber, and the concept of cognitive shuffling as a tool for letting sleep come rather than chasing it.
A sleep medicine doctor cuts through the myths, gadget hype, and pill dependency that keep health-conscious adults -- especially perimenopausal and postmenopausal women -- from sleeping well. If you have ever poured a nightcap to wind down, obsessed over your Oura Ring data, or wondered whether your sleeping pill is actually helping, this episode gives you the clinical grounding to stop doing the things that are making it worse.
Dr. Benji Ozynski from the Sleep Health Centre South Africa joins nutritionist Nicci Robertson to explain what sleep actually is, why it cannot be hacked or forced, and what a medically trained sleep specialist looks for before reaching for a prescription pad. They cover how estrogen, progesterone, and vasomotor symptoms derail sleep in perimenopause; why postmenopausal women carry the same obstructive sleep apnea risk as men; and the cardiovascular, metabolic, and neurocognitive consequences of untreated OSA -- from atrial fibrillation and insulin resistance to increased dementia risk.
On sleeping pills, Dr. Ozynski breaks down every major category: benzodiazepines, z-drugs (zolpidem, zopiclone, Stilnox, Ambien), antihistamines, low-dose antipsychotics (quetiapine), older antidepressants (trazodone), and the newer DORA drugs (daridorexant, Quviviq) that block wakefulness rather than force sedation. He explains why tolerance stacking happens, when short-term use is clinically appropriate, and why cognitive behavioural therapy for insomnia (CBT-I) must sit underneath any pharmacological approach.
The episode also addresses why alcohol and THC obliterate REM sleep, what orthosomnia is and why financial penalties tied to wearable sleep scores are likely to backfire, how chronotype is genetically driven and why fighting it is counterproductive, and the three-stage model of how acute stress tips a predisposed brain into chronic insomnia. Practical takeaways include sleep regularity, the one-hour wind-down routine outside the bedroom, caffeine cutoff timing based on adenosine receptor biology, meal timing and blood sugar stability, morning sunlight as a circadian zeitgeber, and the concept of cognitive shuffling as a tool for letting sleep come rather than chasing it.